Gastroenterology and Liver Diseases

Gastrointestinal Oncology

Gastrointestinal Oncology Branch was established to integrate and synergize multidisciplinary clinical pertaining to cancers of the lungs, chest cavity and gastrointestinal tract. Our team approach to thoracic and gastrointestinal malignancies is designed to hasten the development of novel treatments for a wide range of cancers that affect more than a half million patients per year. But are not limited to, cancers of the lung, thymus, pleura and chest wall, oesophagus, stomach, liver, bile ducts, pancreas and intestines. The TGIB was a large branch of NCI that spans the spectrum of basic research, clinical trials and patient care all aimed at better detection, prevention and treatment of patients with these cancers.